![]() |
市場調査レポート
商品コード
1541681
大腸菌検査市場レポート:製品、検査タイプ、エンドユーザー、地域別、2024~2032年E. Coli Testing Market Report by Product (Consumables, Instruments), Test Type (Environmental Test, Clinical Test), End User (Hospitals and Clinics, Diagnostic Laboratories, and Others), and Region 2024-2032 |
||||||
カスタマイズ可能
|
大腸菌検査市場レポート:製品、検査タイプ、エンドユーザー、地域別、2024~2032年 |
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2~3営業日
|
世界の大腸菌検査市場規模は2023年に21億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに39億米ドルに達し、2024~2032年の間に6.6%の成長率(CAGR)を示すと予測しています。
大腸菌(E. Coli)検査とは、食品由来病原体の存在を検出・監視するプロセスを指します。大腸菌は通常、汚染された食品や水、生乳から製造されたチーズ、加熱不十分な製品、未殺菌乳、生の果物や野菜から検出されます。食中毒、肺炎、尿路感染症(UTI)など様々な病気を引き起こす可能性があります。大腸菌を検出する臨床検査法には、酵素免疫測定法(EIA)やポリメラーゼ連鎖反応法(PCR)、酵素基質法、膜濾過法、多管発酵法(MTF)などの環境検査法があります。これらの技術は、サンプル中に存在する総大腸菌群や細菌を正確かつ定量的に測定するのに役立ちます。
下痢や溶血性尿毒症症候群(HUS)のような水を媒介とする疾病の有病率の増加と、清潔な飲料水に対する世界のニーズの高まりは、市場展望を明るくする重要な要因の一つです。大腸菌検査は、病気や疾患の蔓延を防ぐため、地表水や飲料水の水質モニタリングに役立ちます。さらに、菌の有無(P/A)検査として酵素基質検査が広く採用されていることも、市場の成長を後押ししています。これらの検査は実施が容易で、高度な実験装置を必要とせず、加水分解可能な蛍光基質を使用して細菌が産生する様々な酵素の存在を検出します。さらに、革新的な細菌診断機器や水質検査法の市場開拓など、さまざまな技術の進歩も市場成長に寄与しています。その他の要因としては、大衆の健康意識の高まり、微生物学セグメントにおける広範な研究開発(R&D)活動などが挙げられ、市場のさらなる牽引役となることが期待されます。
The global E. coli testing market size reached US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.9 Billion by 2032, exhibiting a growth rate (CAGR) of 6.6% during 2024-2032.
Escherichia coli (E. Coli) testing refers to the process of detecting and monitoring the presence of foodborne pathogens. E. Coli bacteria is usually found in contaminated food and water, cheese manufactured from raw milk, undercooked products, unpasteurized milk and raw fruits and vegetables. It can cause various diseases, such as food poisoning, pneumonia and urinary tract infections (UTIs). Some of the clinical testing methods for the detection of E. Coli include enzyme immunoassays (EIA) and polymerase chain reaction (PCR) tests, along with environmental testing methods, such as enzyme-substrate, membrane filtration and multiple tube fermentation (MTF). These techniques aid in obtaining an accurate and quantitative measure of total coliform and bacteria present in the sample.
The increasing prevalence of water-borne diseases, such as diarrhea and hemolytic uremic syndrome (HUS), along with the growing need for clean potable water across the globe, is one of the key factors creating a positive outlook for the market. E. Coli tests can aid in monitoring the quality of surface and drinking water to prevent the spread of illnesses and diseases. Furthermore, the widespread adoption of the enzyme-substrate test as a presence or absence (P/A) test is also driving the market growth. These tests are easy to perform, do not require sophisticated laboratory equipment and use hydrolyzable fluorogenic substrates to detect the presence of various enzymes produced by the bacteria. Additionally, various technological advancements, such as the development of innovative bacterial diagnostic instruments and water testing methods, are contributing to the market growth. Other factors, including increasing health consciousness among the masses, along with extensive research and development (R&D) activities in the field of microbiology, are expected to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global E. coli testing market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, test type and end user.
Consumables
Instruments
Environmental Test
Membrane Filtration (MF)
Multiple Tube Fermentation (MTF)
Enzyme Substrate Methods
Clinical Test
Polymerase Chain Reaction (PCR) Tests
Enzyme Immunoassays (EIA)
Others
Hospitals and Clinics
Diagnostic Laboratories
Others
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also analysed the competitive landscape of the market with some of the key players being Accugen Laboratories Inc., Alere Inc. (Abbott Laboratories), BD (Becton Dickinson and Company), bioMerieux (INSTITUT MERIEUX), Bio-RAD Laboratories Inc., Enzo Life Sciences Inc. (Enzo Biochem Inc.), Idexx Laboratories Inc., Johnson & Johnson, Meridian Bioscience Inc., Nanologix Inc., Pro-Lab Diagnostics, Qiagen N.V. and Thermo Fisher Scientific Inc.